Loading... 2 0 20 0 false
Amanda Cano holds a postdoctoral researcher position in the clinical research department of Ace Alzheimer Center Barcelona. Previously, she was an adjunct professor of Physical Chemistry at the University of Barcelona. She graduated from Pharmacy at the University of Salamanca in 2013 and received her master’s degree in 2014 from the University of Barcelona. In 2018, she finished her Ph.D. studies on nanomedicine and neuropharmacology, and obtained the doctoral degree from the University of Barcelona. In this period, she also combined experimental activity with teaching experience. She carried out several international research stays at the University of Trás-os-Montes and Alto Douro in Portugal, the University College of London in the United Kingdom, and the University of Modena and Reggio Emilia in Italy. She is a member of the Consolidated Research Group of the Generalitat de Catalunya “Nanostructured systems for the controlled release of drugs” (2017SGR-1477), Institute of Nanoscience and Nanotechnology (IN2UB), and Center for Biomedical Research in Neurodegenerative Diseases Network (CIBERNED). She has obtained several competitive fellowships to develop her scientific career, and possess the official credentials of Assistant Professor of the National Agency for Evaluation and Accreditation (ANECA) of the Ministry of Science (Spanish government) and of the Agency for the Quality of the University System of Catalonia (AQU) (Generalitat of Catalunya). She has participated in several competitive European projects, competitive national projects, and non-competitive national and international projects. In 2020, she started her postdoctoral studies related to clinical evaluation of early biomarkers of Alzheimer’s disease. Likewise, she participates as a pharmacist in clinical trials at the Ace Alzheimer Center Barcelona, having participated in multiple clinical trials on Alzheimer’s disease to date.
Loading... 3 0 20 0 false
- 11 2000 - 2024
Results 1-11 of 11 (Search time: 0.009 seconds).
|1||Aug-2022||Biodegradable nanoparticles for the treatment of epilepsy: From current advances to future challenges||Bonilla, Lorena; Esteruelas, Gerard; Ettcheto, Miren; Espina, Marta; García, María Luisa; Camins, Antoni; Souto, Eliana B. ; Cano, Amanda ; Sánchez-López, Elena||article||openAccess|
|2||9-Sep-2021||Elastic and Ultradeformable Liposomes for Transdermal Delivery of Active Pharmaceutical Ingredients (APIs)||Souto, Eliana ; Macedo, Ana S; Dias-Ferreira, João ; Cano, Amanda ; Zielińska, Aleksandra ; Matos, Carla M.||article||openAccess|
|3||18-Oct-2021||Epilepsy in Neurodegenerative Diseases: Related Drugs and Molecular Pathways||Cano, Amanda ; Fonseca, Elena; Ettcheto, Miren; Sánchez-López, Elena; de Rojas, Itziar; Alonso-Lana, Silvia; Morató, Xavier; Souto, Eliana B. ; Toledo, Manuel; Boada, Mercè ; Marquié, Marta; Ruíz, Agustín||article||openAccess|
|4||4-Aug-2021||Lipid-Polymeric Films: Composition, Production and Applications in Wound Healing and Skin Repair||Souto, Eliana B. ; Yoshida, Cristiana M. P.; Leonardi, Gislaine R.; Cano, Amanda ; Sanchez-Lopez, Elena; Zielińska, Aleksandra ; Viseras, César; Severino, Patrícia ; Silva, Classius F. da; Barbosa, Raquel de M.||article||openAccess|
|5||27-Mar-2018||Memantine loaded PLGA PEGylated nanoparticles for Alzheimer's disease: in vitro and in vivo characterization||Sánchez-López, Elena ; Ettcheto, Miren; Egea, Maria Antonia; Espina, Marta; Cano, Amanda ; Calpena, Ana Cristina; Camins, Antoni; Carmona, Nuria; Silva, Amelia M.; Souto, Eliana B. ; García, Maria Luisa||article||openAccess|
|6||9-Feb-2020||Metal-Based Nanoparticles as Antimicrobial Agents: An Overview||Sánchez-López, Elena; Gomes, Daniela ; Esteruelas, Gerard; Bonilla, Lorena; Lopez-Machado, Ana Laura; Galindo, Ruth; Cano, Amanda ; Espina, Marta; Ettcheto, Miren; Camins, Antoni; Silva, Amélia M.; Durazzo, Alessandra; Santini, Antonello; Garcia, Maria L. ; Souto, Eliana B.||article||openAccess|
|7||29-Apr-2021||Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer's disease: from current to future challenges||Cano, Amanda ; Turowski, Patric; Ettcheto, Miren; Duskey, Jason Thomas; Tosi, Giovanni; Sánchez-López, Elena; García, Maria Luisa; Camins, Antonio; Souto, Eliana B. ; Ruiz, Agustín; Marquié, Marta; Boada, Mercè||article||openAccess|
|8||Feb-2022||Physicochemical and biopharmaceutical aspects influencing skin permeation and role of SLN and NLC for skin drug delivery||Souto, Eliana ; Fangueiro, Joana F. ; Fernandes, Ana R. ; Cano, Amanda ; Sanchez-Lopez, Elena; Garcia, Maria L. ; Severino, Patrícia; Paganelli, Maria O.; Chaud, Marco V.; Silva, Amélia M.||article||openAccess|
|9||7-May-2021||Psoriasis: From Pathogenesis to Pharmacological and Nano-Technological-Based Therapeutics||Petit, Robert Gironés; Cano, Amanda ; Ortiz, Alba; Espina, Marta; Prat, Josefina; Muñoz, Montserrat; Severino, Patrícia; Souto, Eliana B. ; Garcia, Maria L. ; Pujol, Montserrat; Sánchez-López, Elena||article||openAccess|
|10||23-Aug-2021||State of the Art on Toxicological Mechanisms of Metal and Metal Oxide Nanoparticles and Strategies to Reduce Toxicological Risks||García-Torra, Victor; Cano, Amanda ; Espina, Marta; Ettcheto, Miren; Camins, Antoni; Barroso, Emma; Vazquez-Carrera, Manel; García, Maria Luisa; Sánchez-López, Elena; Souto, Eliana B.||article||openAccess|
|11||2021||Surface Functionalization of PLGA Nanoparticles to Increase Transport across the BBB for Alzheimer’s Disease||Del Amo, Laura; Cano, Amanda ; Ettcheto, Miren; Souto, Eliana B. ; Espina, Marta; Camins, Antoni; García, Maria Luísa; Sánchez-López, Elena||article||openAccess|